Emily Hartman Guthrie

Emily Hartman Guthrie currently serves as the Director of Business Insights and Market Intelligence at Aldevron since November 2025. Previously, Emily held roles as Research Lead and Senior Research Associate at Patient Square Capital from April 2021 to October 2025, contributing to investments in health care. Prior experience includes a Management Consultant position at Boston Consulting Group from July 2019 to April 2021, where strategic visions and digital therapeutics were developed for the biopharma sector. Emily completed a PhD at the University of California, Berkeley, focusing on protein engineering and biomaterials, and has held various research and editorial positions, including a Research Associate role at the Broad Institute of MIT and Harvard, and Editor in Chief of the Berkeley Science Review. Academic credentials include a Bachelor of Science in Chemistry from Brown University.